117 Aufrufe 117 0 Kommentare 0 Kommentare

    Levi & Korsinsky Urges RxSight, Inc. (RXST) Shareholders to Act Before Lead Plaintiff Deadline September 22, 2025

    New York, New York--(Newsfile Corp. - September 18, 2025) - If you suffered a loss on your RxSight, Inc. (NASDAQ: RXST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

    https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=16827 ...

    or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.

    Cannot view this image? Visit: https://images.newsfilecorp.com/files/7091/267073_167219_logo.jpg



    Cannot view this video? Visit:
    https://www.youtube.com/watch?v=irbdmq7wopw

    THE LAWSUIT: A class action securities lawsuit was filed against RxSight, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between May 7, 2024 and July 8, 2025.

    CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the Company was experiencing "adoption challenges" and/or structural issues resulting in declines in sales and utilization; (2) defendants had overstated the demand for RxSight's products; (3) as a result, RxSight was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and (4) that, as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

    WHAT'S NEXT? If you suffered a loss in RxSight, Inc. stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=16827 ... to learn about your rights to seek a recovery. There is no cost or obligation to participate.

    WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

    CONTACT:
    Levi & Korsinsky, LLP
    Joseph E. Levi, Esq.
    Ed Korsinsky, Esq.
    33 Whitehall Street, 17th Floor
    New York, NY 10004
    jlevi@levikorsinsky.com
    Tel: (212) 363-7500
    Fax: (212) 363-7171
    https://zlk.com/

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/267073


    The RxSight Stock at the time of publication of the news with a raise of +5,92 % to 9,49USD on Nasdaq stock exchange (18. September 2025, 22:30 Uhr).



    newsfile
    0 Follower
    Autor folgen

    Verfasst von newsfile
    Levi & Korsinsky Urges RxSight, Inc. (RXST) Shareholders to Act Before Lead Plaintiff Deadline September 22, 2025 New York, New York--(Newsfile Corp. - September 18, 2025) - If you suffered a loss on your RxSight, Inc. (NASDAQ: RXST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more …